Mark G. Hebert, NP
Nurse Practitioner in Atlanta, GA
About Mark Hebert
Mark Hebert is a nurse practitioner practicing in Atlanta, GA. Records list 3 practice addresses. Treated 38 Medicare patients in 2024.
| Specialty | Nurse PractitionerOther nurse practitioners in Atlanta |
|---|---|
| Credentials | NP |
| Gender | Male |
| NPI number | 1831268630National Provider Identifier (CMS NPPES), issued November 2006 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Where Mark Hebert practices
- AvitaCare 2140 Peachtree Rd NW, Suite 232, Atlanta, GA 30309 (404) 231-4431 · Directions · group of 13 clinicians
- AvitaCare 2140 Peachtree Rd NW, Suite 232, Atlanta, GA 30309 (404) 231-4431 · Directions · group of 16 clinicians
- MedCura Buckhead 2140 Peachtree Rd NW Ste 232, Atlanta, GA 30309 (404) 231-4431 · Directions
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Mark Hebert's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Nurse Practitioner Primary | GA RN116170 |
| Nurse Practitioner | GA RN116170 NP |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Mark Hebert's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Detection test by nucleic acid for hiv-1 virus, quantification | 88 | $83.40 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 84 | $7.61 |
| Blood test, comprehensive group of blood chemicals | 83 | $10.35 |
| Blood test, lipids (cholesterol and triglycerides) | 52 | $13.12 |
| Insertion of needle into vein for collection of blood sample | 32 | $8.65 |
| Hemoglobin a1c level | 30 | $9.52 |
| Vitamin d-3 level | 26 | $29.01 |
| Urine microalbumin (protein) level | 24 | $5.66 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Mark Hebert (2025)
$1,002.21 in 51 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 51 | $1,002.21 |
Paying companies: ViiV Healthcare Company ($457.87), Gilead Sciences, Inc. ($187.67), Merck Sharp & Dohme LLC ($135.41), Novo Nordisk Inc ($54.86), Verity Pharmaceuticals Inc. ($47.77), Theratechnologies Inc. ($45.38).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Mark Hebert
What kind of clinician is Mark Hebert?
Mark Hebert is listed as a nurse practitioner.
Where does Mark Hebert practice?
AvitaCare at 2140 Peachtree Rd NW, Suite 232, Atlanta, GA 30309, and 2 other addresses in the records.
What is the office phone number for Mark Hebert?
The listed office number is (404) 231-4431. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Mark Hebert?
The National Provider Identifier is 1831268630.
Does Mark Hebert accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2018-06-16 |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.